FIELD: biotechnology. SUBSTANCE: invention relates to production of medicinal biological preparations. Method involves culturing bacteria and bacteriophages Staphylococcus, Streptococcus, Proteus, Klebsiella, Escherichia coli, Pseudomonas aeruginosa in liquid nutrient medium. Each species of bacterium and bacteriophage is cultured separately. Culturing is carried out under condition of intensive aeration and stirring at 30-70% of saturation of cultural medium with dissolved oxygen and using exponentially multiplied bacterial population. Obtained phagolysates of all bacteriophages are combined, stirred and subjected for micro- and ultrafiltration in regime of tangential flow through membranes (pore size is 0.2-0.8 mcm and threshold value of substance retention is 150-200 kDa) followed by final sterilizing microfiltration. Purification degree of bacteriophages from metabolites of bacteria and proteins is 98 ± 1.5%. EFFECT: broadened spectrum of antibacterial activity of preparation. 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
BIOPHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL AND PROBIOTIC ACTIVITY AND DOSAGE FORM BASED ON IT | 2021 |
|
RU2795770C2 |
ANTIBACTERIAL PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING BACTERIOPHAGES | 2016 |
|
RU2660355C2 |
STRAIN OF BACTERIOPHAGE Staphylococcus aureus SA20 ENSURING DESTRUCTION OF BIOFILMS CREATED BY BACTERIA OF Staphylococcus FAMILY | 2014 |
|
RU2565824C1 |
STRAIN OF BACTERIOPHAGE Citrobacter freundii CF17 ABLE TO LYSE PATHOGENIC STRAINS CITROBACTER FREUNDII | 2014 |
|
RU2565559C1 |
METHOD FOR PREVENTION OF HEALTHCARE-ASSOCIATED INFECTIONS IN PATIENTS IN CHRONIC CRITICAL CONDITION | 2023 |
|
RU2818910C1 |
BACTERIOPHAGE-CONTAINING ROOM DEODORANT | 2014 |
|
RU2574023C2 |
SEXTAPHAGE (PYOBACTERIOPHAGE POLYVALENT) OR BACTERIOPHAGE SALMONELLOUS PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2410084C1 |
METHOD FOR THE TREATMENT AND PREVENTION OF RECURRENCE OF NOSOCOMIAL PNEUMONIA | 2021 |
|
RU2794585C2 |
SUPPOSITORY | 2000 |
|
RU2185817C2 |
METHOD FOR PREVENTION OF POSTOPERATIVE INFECTIOUS COMPLICATIONS IN NEUROSURGICAL PATIENTS IN CHRONIC CRITICAL CONDITION CAUSED BY BRAIN INJURY | 2023 |
|
RU2817214C1 |
Authors
Dates
2000-07-27—Published
1999-01-20—Filed